This really says it all. At least 80% of the posts I've read in this thread belie their authors total lack of understanding of the announcement.
I am loathe to even explain it, yet i find myself compelled. The result was only 6% off the anticipated 58%. If we use the more effective of the two delivery methods, we actually got 60% which is 2% higher than expectations.
And here half the thread is declaring it a failed trial? And to top it all off, these people have so much faith in their abilities that they think they can beat the market, or else they'd just put their money in an index fund. Its phenomenal. Absolutely phenomenal.
Ann: Admedus Releases Results of HSV-2 Phase IIa Study, page-136
-
- There are more pages in this discussion • 215 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.19 |
Change
-0.010(0.08%) |
Mkt cap ! $257.6M | |||
| Open | High | Low | Value | Volume |
| $12.19 | $12.20 | $11.60 | $173.1K | 14.51K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9 | $11.97 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.19 | 28 | 1 |
View Market Depth
| Last trade - 16.10pm 01/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |